Table 1 Patient characteristics
| Number of patients | n = 41 | |
|---|---|---|
| Age | Median | Range |
| 69 | 60–92 | |
| Race | n | % |
| Caucasian | 26 | 63% |
| African-American | 15 | 37% |
| Prostate volume (cc) | Median | Range |
| 37 | 20–63 | |
| PSA (ng/mL) | Median | Range |
| 6.9 | 3.5–18.3 | |
| T Stage | n | % |
| 1b | 1 | 2% |
| 1c | 28 | 68% |
| 2a | 6 | 15% |
| 2b | 4 | 10% |
| 2c | 2 | 5% |
| Gleason score | n | % |
| 3+3 | 9 | 22% |
| 3+4 | 23 | 56% |
| 4+3 | 9 | 22% |
| Number of risk factors* | n | % |
| 1 | 34 | 83% |
| 2 | 7 | 17% |
| 3 | 0 | 0% |
